SREA Fundamental Analysis - SEMPRA - SRE 5 3/4 07/01/2079

Fundamental Rating

SREA gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 25 industry peers in the Multi-Utilities industry. While SREA is still in line with the averages on profitability rating, there are concerns on its financial health. SREA has a valuation in line with the averages, but it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

SREA had positive earnings in the past year.

SREA had a positive operating cash flow in the past year.

In the past 5 years SREA has always been profitable.

Each year in the past 5 years SREA had a positive operating cash flow.

1.2 Ratios

SREA has a Return On Assets (2.67%) which is comparable to the rest of the industry.

SREA's Return On Equity of 8.42% is in line compared to the rest of the industry. SREA outperforms 44.00% of its industry peers.

SREA has a Return On Invested Capital of 2.77%. This is amonst the worse of the industry: SREA underperforms 92.00% of its industry peers.

SREA had an Average Return On Invested Capital over the past 3 years of 3.30%. This is in line with the industry average of 3.82%.

		Industry Rank	Sector Rank
ROA	2.67%
ROE	8.42%
ROIC	2.77%

ROA(3y)3.02%

ROA(5y)3.29%

ROE(3y)9.1%

ROE(5y)9.64%

ROIC(3y)3.3%

ROIC(5y)3.52%

1.3 Margins

Looking at the Profit Margin, with a value of 20.02%, SREA belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.

SREA's Profit Margin has improved in the last couple of years.

The Operating Margin of SREA (22.76%) is better than 72.00% of its industry peers.

SREA's Operating Margin has declined in the last couple of years.

		Industry Rank	Sector Rank
OM	22.76%
PM (TTM)	20.02%
GM	N/A

OM growth 3Y0.45%

OM growth 5Y-2.46%

PM growth 3Y29.87%

PM growth 5Y2.38%

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SREA is destroying value.

SREA has more shares outstanding than it did 1 year ago.

Compared to 5 years ago, SREA has more shares outstanding

Compared to 1 year ago, SREA has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 0.56, we must say that SREA is in the distress zone and has some risk of bankruptcy.

With a Altman-Z score value of 0.56, SREA is not doing good in the industry: 88.00% of the companies in the same industry are doing better.

SREA has a Debt/Equity ratio of 1.17. This is a high value indicating a heavy dependency on external financing.

With an excellent Debt to Equity ratio value of 1.17, SREA belongs to the best of the industry, outperforming 84.00% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	1.17
Debt/FCF	N/A
Altman-Z	0.56

ROIC/WACC0.57

WACC4.87%

2.3 Liquidity

SREA has a Current Ratio of 0.48. This is a bad value and indicates that SREA is not financially healthy enough and could expect problems in meeting its short term obligations.

Looking at the Current ratio, with a value of 0.48, SREA is doing worse than 92.00% of the companies in the same industry.

SREA has a Quick Ratio of 0.48. This is a bad value and indicates that SREA is not financially healthy enough and could expect problems in meeting its short term obligations.

Looking at the Quick ratio, with a value of 0.41, SREA is doing worse than 88.00% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	0.48
Quick Ratio	0.41

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 6.31% over the past year.

The Earnings Per Share has been decreasing by -5.31% on average over the past years.

SREA shows a decrease in Revenue. In the last year, the revenue decreased by -1.04%.

The Revenue has been growing slightly by 4.04% on average over the past years.

EPS 1Y (TTM)6.31%

EPS 3Y-18.2%

EPS 5Y-5.31%

EPS Q2Q%0%

Revenue 1Y (TTM)-1.04%

Revenue growth 3Y0.84%

Revenue growth 5Y4.04%

Sales Q2Q%-0.37%

3.2 Future

Based on estimates for the next years, SREA will show a small growth in Earnings Per Share. The EPS will grow by 7.04% on average per year.

The Revenue is expected to grow by 2.62% on average over the next years.

EPS Next Y-1.2%

EPS Next 2Y4.82%

EPS Next 3Y6.01%

EPS Next 5Y7.04%

Revenue Next Year-9.66%

Revenue Next 2Y-2.27%

Revenue Next 3Y-0.3%

Revenue Next 5Y2.62%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 4.97, which indicates a rather cheap valuation of SREA.

SREA's Price/Earnings ratio is rather cheap when compared to the industry. SREA is cheaper than 88.00% of the companies in the same industry.

When comparing the Price/Earnings ratio of SREA to the average of the S&P500 Index (27.38), we can say SREA is valued rather cheaply.

With a Price/Forward Earnings ratio of 4.62, the valuation of SREA can be described as very cheap.

Compared to the rest of the industry, the Price/Forward Earnings ratio of SREA indicates a rather cheap valuation: SREA is cheaper than 88.00% of the companies listed in the same industry.

The average S&P500 Price/Forward Earnings ratio is at 22.86. SREA is valued rather cheaply when compared to this.

		Industry Rank	Sector Rank
PE	4.97
Fwd PE	4.62

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SREA is valued a bit cheaper than 68.00% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	9.24

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y4.82%

EPS Next 3Y6.01%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

SREA has a Yearly Dividend Yield of 3.13%.

With a Dividend Yield of 3.13, SREA pays less dividend than the industry average, which is at 4.63. 80.00% of the companies listed in the same industry pay a better dividend than SREA!

SREA's Dividend Yield is a higher than the S&P500 average which is at 2.38.

		Industry Rank	Sector Rank
Dividend Yield	3.13%

5.2 History

The dividend of SREA decreases each year by -9.71%.

SREA has been paying a dividend for over 5 years, so it has already some track record.

SREA has decreased its dividend recently.

Dividend Growth(5Y)-9.71%

Div Incr Years0

Div Non Decr Years1

5.3 Sustainability

59.51% of the earnings are spent on dividend by SREA. This is a bit on the high side, but may be sustainable.

DP59.51%

EPS Next 2Y4.82%

EPS Next 3Y6.01%

More info and screens

Find the best dividend stocks

Show peers with best dividend

SEMPRA - SRE 5 3/4 07/01/2079

NYSE:SREA (9/19/2025, 8:04:00 PM)

23.44

+0.29 (+1.25%)

Chartmill FA Rating

GICS SectorUtilities

GICS IndustryGroupUtilities

GICS IndustryMulti-Utilities

Earnings (Last)08-07 2025-08-07/bmo

Earnings (Next)11-04 2025-11-04/bmo

Inst Owners95.23%

Inst Owner ChangeN/A

Ins Owners0.04%

Ins Owner ChangeN/A

Market Cap15.29B

Analysts74

Price Target24.21 (3.28%)

Short Float %0.01%

Short Ratio1.02

Dividend

		Industry Rank	Sector Rank
Dividend Yield	3.13%

Yearly Dividend2.41

Dividend Growth(5Y)-9.71%

DP59.51%

Div Incr Years0

Div Non Decr Years1

Ex-Date09-15 2025-09-15 (0.359375)

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)6.09%

Min EPS beat(2)4.16%

Max EPS beat(2)8.03%

EPS beat(4)2

Avg EPS beat(4)-2.82%

Min EPS beat(4)-16.27%

Max EPS beat(4)8.03%

EPS beat(8)4

Avg EPS beat(8)-1.5%

EPS beat(12)8

Avg EPS beat(12)1.82%

EPS beat(16)11

Avg EPS beat(16)2.7%

Revenue beat(2)0

Avg Revenue beat(2)-3.99%

Min Revenue beat(2)-4.09%

Max Revenue beat(2)-3.89%

Revenue beat(4)0

Avg Revenue beat(4)-11.25%

Min Revenue beat(4)-22.35%

Max Revenue beat(4)-3.89%

Revenue beat(8)0

Avg Revenue beat(8)-15%

Revenue beat(12)2

Avg Revenue beat(12)-5.44%

Revenue beat(16)6

Avg Revenue beat(16)-1.39%

PT rev (1m)6.78%

PT rev (3m)5.5%

EPS NQ rev (1m)-1.08%

EPS NQ rev (3m)0.17%

EPS NY rev (1m)0%

EPS NY rev (3m)-0.01%

Revenue NQ rev (1m)1.67%

Revenue NQ rev (3m)-3.75%

Revenue NY rev (1m)-1.1%

Revenue NY rev (3m)-2.76%

Valuation

		Industry Rank	Sector Rank
PE	4.97
Fwd PE	4.62
P/S	1.15
P/FCF	N/A
P/OCF	3.29
P/B	0.48
P/tB	0.51
EV/EBITDA	9.24

EPS(TTM)4.72

EY20.14%

EPS(NY)5.08

Fwd EY21.66%

FCF(TTM)-8.26

FCFYN/A

OCF(TTM)7.13

OCFY30.42%

SpS20.44

BVpS48.61

TBVpS45.73

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	2.67%
ROE	8.42%
ROCE	3.32%
ROIC	2.77%
ROICexc	2.78%
ROICexgc	2.83%
OM	22.76%
PM (TTM)	20.02%
GM	N/A
FCFM	N/A

ROA(3y)3.02%

ROA(5y)3.29%

ROE(3y)9.1%

ROE(5y)9.64%

ROIC(3y)3.3%

ROIC(5y)3.52%

ROICexc(3y)3.32%

ROICexc(5y)3.56%

ROICexgc(3y)3.41%

ROICexgc(5y)3.66%

ROCE(3y)3.99%

ROCE(5y)4.26%

ROICexcg growth 3Y-8.37%

ROICexcg growth 5Y-5.96%

ROICexc growth 3Y-8.1%

ROICexc growth 5Y-5.8%

OM growth 3Y0.45%

OM growth 5Y-2.46%

PM growth 3Y29.87%

PM growth 5Y2.38%

GM growth 3YN/A

GM growth 5YN/A

F-Score4

Asset Turnover0.13

Health

		Industry Rank	Sector Rank
Debt/Equity	1.17
Debt/FCF	N/A
Debt/EBITDA	6.68
Cap/Depr	396.53%
Cap/Sales	75.31%
Interest Coverage	2.3
Cash Conversion	83.55%
Profit Quality	N/A
Current Ratio	0.48
Quick Ratio	0.41
Altman-Z	0.56

F-Score4

WACC4.87%

ROIC/WACC0.57

Cap/Depr(3y)359.34%

Cap/Depr(5y)353.45%

Cap/Sales(3y)54.96%

Cap/Sales(5y)53.03%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)6.31%

EPS 3Y-18.2%

EPS 5Y-5.31%

EPS Q2Q%0%

EPS Next Y-1.2%

EPS Next 2Y4.82%

EPS Next 3Y6.01%

EPS Next 5Y7.04%

Revenue 1Y (TTM)-1.04%

Revenue growth 3Y0.84%

Revenue growth 5Y4.04%

Sales Q2Q%-0.37%

Revenue Next Year-9.66%

Revenue Next 2Y-2.27%

Revenue Next 3Y-0.3%

Revenue Next 5Y2.62%

EBIT growth 1Y9.84%

EBIT growth 3Y1.29%

EBIT growth 5Y1.48%

EBIT Next Year59%

EBIT Next 3Y22.19%

EBIT Next 5Y14.33%

FCF growth 1Y-0.07%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y84.97%

OCF growth 3Y8.5%

OCF growth 5Y9.71%

SEMPRA - SRE 5 3/4 07/01/2079 (SREA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens